Tevogen Bio Holdings (TVGN) Other Non-Current Assets (2021 - 2026)
Tevogen Bio Holdings (TVGN) reported Other Non-Current Assets of $1.1 million for Q1 2026, up 85.1% on a YoY basis from $575841.0 in Q1 2025, and little changed quarter-over-quarter from $1.1 million in Q4 2025.
Tevogen Bio Holdings (TVGN) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Tevogen Bio Holdings has reported Other Non-Current Assets for 6 years, with the latest figure at $1.1 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 85.1% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 85.1% YoY), and the FY2025 full-year result was $1.1 million, up 85.1% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $1.1 million, roughly flat from $1.1 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $2.6 million in Q4 2023, with the low at $38947.0 in Q1 2022.
- Historically, Other Non-Current Assets has averaged $641991.4 across 5 years, with a median of $565884.0 in 2025.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 77.71% — and 2025, when it jumped 332.07%.
- Tevogen Bio Holdings' Other Non-Current Assets stood at $38947.0 in 2022, then surged by 6531.76% to $2.6 million in 2023, then sank by 77.71% to $575841.0 in 2024, then jumped by 85.1% to $1.1 million in 2025, then grew by 0.0% to $1.1 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $190923.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Tevogen Bio Holdings | 182.04 Mn | 181.35 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 190,923.00 |
| Jun 30, 2025 | 565,884.00 |
| Mar 31, 2025 | 575,841.00 |
| Dec 31, 2024 | 575,841.00 |
| Sep 30, 2024 | 133,276.00 |
| Jun 30, 2024 | 133,276.00 |
| Mar 31, 2024 | 133,276.00 |
| Dec 31, 2023 | 2.58 Mn |
| Mar 31, 2022 | 38,947.00 |
| Dec 31, 2021 | 145,170.00 |